A Study of Tirzepatide (LY3298176) in Healthy Lactating Females
Clinical trial NCT05978713 · COMPLETED
Trial details
- NCT number
- NCT05978713
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-31
- Primary completion
- 2024-03-12
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.